Metformin Use in Populations With CKD, CHF, or CLD – Annals of Internal Medicine -American College of Physicians

On By SupremeCmdrIn Uncategorized
Conclusion: Metformin use in patients with moderate CKD, CHF, or CLD with hepatic impairment is associated with improvements in key clinical outcomes. Our findings support the recent changes in metformin labeling.

Source: Metformin Use in Populations With CKD, CHF, or CLD | Annals of Internal Medicine | American College of Physicians

Advertisements

Leave a Reply

Please log in using one of these methods to post your comment:

Gravatar
WordPress.com Logo

You are commenting using your WordPress.com account. ( Log Out /  Change )

Google photo

You are commenting using your Google account. ( Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. ( Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. ( Log Out /  Change )

Cancel

Connecting to %s